[
    [
        {
            "time": "",
            "original_text": "云南白药吸并演绎新玩法 陈发树200亿混改入资的“证券化”样本",
            "features": {
                "keywords": [
                    "云南白药",
                    "吸并",
                    "陈发树",
                    "200亿",
                    "混改",
                    "证券化"
                ],
                "sentiment_score": 0.75,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "云南白药吸并演绎新玩法 陈发树200亿混改入资的“证券化”样本",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]